Cross protection studies on Bordetella bronchiseptica in mice using an intracerebral challenge model.
Protective activities of heat-inactivated (60 degrees C for 30 min) merthiolate preserved Bordetella bronchiseptica and B. pertussis bacterins were compared in intraperitoneally immunized mice challenged intracerebrally (i.p./i.c.) or intraperitoneally (i.p./i.p.). In the i.p./i.c. assay (Kendrick test), a B. pertussis bacterin protected mice against challenge with B. pertussis 18-323, as well as against phase I cytotoxic and non-cytotoxic strains of B. bronchiseptica. A B. bronchiseptica bacterin, prepared from a phase I cytotoxic strain, gave protection against two phase I B. bronchiseptica strains, irrespective of their cytotoxin-production. A non-cytotoxic phase I strain of B. bronchiseptica elicited protection against the homologous strain only. Neither cytotoxic nor non-cytotoxic B. bronchiseptica strains protected mice challenged with B. pertussis 18-323. Vaccines prepared from phase III strains of B. bronchiseptica were not protective at all against any of the challenge strains. No such differences in the protective activities of the bacterins could be detected by the i.p./i.p. method. They seem to cross-protect equally well. The results indicate that the Kendrick test may be useful in testing potency of different B. bronchiseptica bacterins.
Lendvai
N
N
HUMAN Institute for Serobacteriological Production and Research, Budapest, Hungary.
Magyar
T
T
Semjén
G
G
D000818:Animals; D001428:Bacterial Vaccines; D001885:Bordetella Infections / Q000517:prevention & control*; D016950:Bordetella bronchiseptica / Q000276:immunology*; D001886:Bordetella pertussis / Q000276:immunology; D005260:Female; D008297:Male; D051379:Mice; D010567:Pertussis Vaccine
D001428:Bacterial Vaccines; D010567:Pertussis Vaccine